Skip to search formSkip to main contentSkip to account menu

BB-2516

Known as: BB 2516, Marimastat BB-2516 
National Institutes of Health

Related topics

Related topics

2 relations
TA-2516

Broader (1)

marimastat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Marimastat in theTreatment of Patients with Biochemically Relapsed Prostate Cancer : AProspective Randomized , Double-Blind , Phase I / II Trial
Purpose: To evaluate the safety and biological activity of three different doses of marimastat given for 6 months to patients… 
2002
2002
Inhibition of metalloproteinases enhances the internalization of anti‐CD30 antibody Ki‐3 and the cytotoxic activity of Ki‐3 immunotoxin
CD30 is selectively expressed on the tumor cells of a variety of malignant disorders of the immune system and can therefore be… 
1999
1999
Enhancement of the surface expression of tumor necrosis factor alpha (TNFalpha) but not the p55 TNFalpha receptor in the THP-1 monocytic cell line by matrix metalloprotease inhibitors.
The monocytic cell line THP-1 can be induced to express and release tumor necrosis factor alpha (TNFalpha) and both TNFalpha… 
Highly Cited
1998
Highly Cited
1998
Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon…
The solubilization of plasma membrane receptors through proteolytic cleavage of the ligand binding domain at the cell surface is… 
1997
1997
Coordinated expression of matrilysin during TPA-induced apoptosis of LNCaP cells: two parallel processes affected by TPA.
Review
1997
Review
1997
Matrix Metalloproteinase Inhibitor Drugs
Summary Overexpression of matrix metalloproteinase (MMP) enzymes has been linked to a variety of chronic diseases. The natural… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)